Search：
All Dates：
- All
- 2026-06-11 [Thursday]
- 2026-06-12 [Friday]
- 2026-06-13 [Saturday]
- 2026-06-14 [Sunday]
All Rooms：
- All
- A1-A (102-107)
- A1-A101
- A1-A102
- A1-A103
- A1-A104
- A1-A (105-107)
- A1-A108
- A1-A109
- A1-A110
- A2-A206
- A2-A207
- A2-A208
- A2-A213
- A2-A214
- A2-A215
- B1 Hall (Poster Area)
- B1 Hall (Exhibition Area)
2026-06-12 (Friday)
A2-A207
08:00-09:20
| HCC Bridge: From Practice to ISMIO-001 Evidence
| NO. | Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 08:00-08:05 |
Opening |
Gao-Jun Teng | Zhongda Hospital, Southeast University, China |
| 2 | 08:05-08:20 |
Interpretation of Chinese Evidence-Based HCC Guidelines |
Ming Zhao | Sun Yat-Sen University Cancer Center, China |
| 3 | 08:20-08:35 |
HCC conversion surgery in the era of immunotherapy |
Hong Jae Chon | CHA Bundang Medical Center, CHA University, Korea |
| 4 | 08:35-08:50 |
Interventional and multidisciplinary oncology for HCC in Japan |
Takeshi Okamoto | Cancer Institute Hospital of Japanese Foundation for Cancer Research |
| 5 | 08:50-09:00 |
Real-World Insights from ISMIO-001 |
Jian Lu | Zhongda Hospital, Southeast University, China |
| 6 | 09:00-09:20 |
Discussion |
A LL |
